CRP and cancer: Lymphocytes inhibit tumor cell proliferation and metastasis by promoting an immune response to the tumor and high CRP levels reflect proliferation and metastasis of tumor cells in patients with advanced cancer, with interleukin levels that can lead to cachexia and malnutrition, resulting in slower clearance of anticancer drugs and increased toxicity associated with therapy (36).